Related Experiment Videos
Quantitative TLC determination of propranolol in human plasma
Journal of Pharmaceutical Sciences
|September 1, 1978
Summary
A new spectrodensitometric assay accurately quantifies propranolol in plasma. This method detects low drug concentrations, aiding therapeutic drug monitoring for patients.
Area of Science:
- Analytical Chemistry
- Pharmacology
Background:
- Accurate quantification of propranolol is crucial for therapeutic drug monitoring.
- Existing methods may have limitations in sensitivity or applicability.
Purpose of the Study:
- To develop and validate a novel spectrodensitometric assay for propranolol determination.
- To assess the assay's sensitivity, linearity, and recovery in biological matrices.
Main Methods:
- Spectrodensitometric analysis of propranolol on silica gel plates.
- Irradiation at 822 nm to measure absorbance.
- Assay validation using spiked plasma samples.
Main Results:
- Detection of propranolol down to 0.10 microgram.
- Linear quantification range established between 0.010 and 0.400 microgram.
- High percent recovery (90.0%–102.0%) from spiked plasma.
Conclusions:
- The developed spectrodensitometric assay is sensitive and reliable for propranolol quantification.
- This method is suitable for determining propranolol levels in patient plasma during therapeutic use.